시장보고서
상품코드
1433286

의약품 도매 및 유통 시장(2024-2034년)

Pharma Wholesale and Distribution Market Report 2024-2034

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 304 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 의약품 도매 및 유통 시장 규모는 2034년까지 연평균 8.7%의 성장률을 기록할 것으로 예상됩니다.

세계 제약 업계는 의약품의 개발, 접근성 및 구매 용이성을 촉진하기 위한 정부의 노력이 눈에 띄게 증가하고 있습니다. 각국 정부는 공중 보건에서 제약 산업이 차지하는 매우 중요한 역할을 점점 더 많이 인식하고 있으며, 의료 문제를 해결하고 국민의 행복을 보장하기 위해 적극적인 조치를 취하고 있습니다. 정부 이니셔티브의 중요한 측면 중 하나는 신제품의 신속한 승인과 시장 진입을 촉진하기 위해 규제 프로세스를 간소화하는 것입니다. 규제 당국은 보다 효율적인 승인 경로를 채택하여 긴급한 의료 수요에 대응하기 위해 의약품, 백신 및 의료기기의 평가를 가속화하고 있습니다. 또한, 각국 정부는 R&D를 위한 환경 조성에 중점을 두고 있으며, 각국 정부는 제약사 및 학술 기관에 장려금, 보조금, 연구비를 제공하고 있습니다. 이러한 이니셔티브는 특히 미충족 의료 수요가 높은 분야에서 혁신을 촉진하는 것을 목표로 하고 있습니다.

세계 의약품 도매 및 유통 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별·지역별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 조사 결과
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
  • COVID-19의 영향 분석
  • Porter's Five Forces 분석
  • PEST 분석

제4장 의약품 도매 및 유통 시장 분석 : 유형별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 도매업체
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별
    • 생산 도매업체
    • 도매상
    • 에이전트·브로커
  • 유통업체
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별
    • 싱글 파티 유통업체
    • 멀티 파티 유통업체

제5장 의약품 도매 및 유통 시장 분석 : 유통 유형별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 윤리적/브랜드 의약품 유통업체
  • 제네릭 의약품 유통업체
  • PCD 프랜차이즈
  • OTC/기관 공급 의약품 유통업체
  • 기타
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제6장 의약품 도매 및 유통 시장 분석 : 제품 유형별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 브랜드 의약품
  • 제네릭 의약품
  • 일반 의약품(OTC)
  • 의료기기
  • 백신
  • 기타
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제7장 의약품 도매 및 유통 시장 분석 : 지역별

  • 주요 조사 결과
  • 시장 규모 추정과 예측

제8장 북미의 의약품 도매 및 유통 시장 분석

제9장 유럽의 의약품 도매 및 유통 시장 분석

제10장 아시아태평양의 의약품 도매 및 유통 시장 분석

제11장 라틴아메리카의 의약품 도매 및 유통 시장 분석

제12장 중동 및 아프리카의 의약품 도매 및 유통 시장 분석

제13장 기업 개요

  • 경쟁 상황
  • 전략적 전망
  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.

제14장 결론·추천사항

  • Visiongain에 의한 결론
  • 진출 기업에 대한 추천사항
KSM 24.03.07

The global Pharma Wholesale and Distribution market is projected to grow at a CAGR of 8.7% by 2034

The Pharma Wholesale and Distribution Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Government Initiatives for Pharmaceutical Products Driving Market Growth

The global pharmaceutical landscape is witnessing a notable surge in government initiatives aimed at fostering the development, accessibility, and affordability of pharmaceutical products. Governments worldwide are increasingly recognizing the pivotal role played by the pharmaceutical industry in public health, and they are taking proactive measures to address healthcare challenges and ensure the well-being of their populations. One prominent aspect of government initiatives involves streamlining regulatory processes to facilitate the faster approval and market entry of new pharmaceutical products. Regulatory agencies are adopting more efficient approval pathways, accelerating the evaluation of drugs, vaccines, and medical devices to address urgent health needs. Additionally, there is a growing emphasis on creating a conducive environment for research and development, with governments offering incentives, grants, and research funding to pharmaceutical companies and academic institutions. These initiatives aim to stimulate innovation, especially in areas where unmet medical needs persist.

Governments are also implementing policies to enhance the affordability and accessibility of pharmaceuticals. Price control mechanisms, generic drug promotion, and the establishment of health insurance schemes contribute to making essential medications more affordable for the general population. Public-private partnerships are increasingly being leveraged to improve healthcare infrastructure, strengthen supply chains, and expand access to pharmaceutical products, particularly in underserved regions.

Stringent Regulations Industry Growth

The pharmaceutical wholesale and distribution market face substantial challenges due to the stringent regulations imposed by governments. While regulations are crucial for ensuring the safety and quality of pharmaceutical products, their strictness can hinder the efficiency of the distribution network. Compliance with these regulations often involves significant financial investments to meet comprehensive quality control measures, implement advanced storage facilities, and ensure adherence to temperature-controlled transportation standards. The extensive documentation and reporting requirements demanded by regulatory bodies can be time-consuming and resource-intensive, impacting operational efficiency. For instance, the Food and Drug Administration (FDA) reigns supreme in regulating pharmaceutical distribution. Their Current Good Manufacturing Practice (CGMP) guidelines set stringent standards for warehousing, transportation, and record-keeping. Wholesalers and distributors need to be licensed by the FDA and comply with rigorous track-and-trace systems to prevent counterfeiting.

What Questions Should You Ask before Buying a Market Research Report?

How is the Pharma Wholesale and Distribution market evolving?

What is driving and restraining the Pharma Wholesale and Distribution market?

How will each Pharma Wholesale and Distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each Pharma Wholesale and Distribution submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading Pharma Wholesale and Distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the Pharma Wholesale and Distribution projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of Pharma Wholesale and Distribution projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the Pharma Wholesale and Distribution market?

Where is the Pharma Wholesale and Distribution market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pharma Wholesale and Distribution market today, and over the next 10 years:

Our 300-page report provides 109 tables and 144 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Pharma Wholesale and Distribution market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Type

Wholesalers: Producer Wholesaler, Merchant Wholesaler, Agents and Brokers

Distributor: Single Party Distributor, Multi Party Distributor

Distribution Type

Ethical/Branded Pharma Products Distributors

Generic Pharma Products Distributors

Propaganda Cum Distribution (PCD) Franchise

OTC/Institutional Supply Pharma Distributors

Others

Product Type

Branded Pharmaceuticals

Generic Pharmaceuticals

Over-the-counter (OTC) Pharmaceuticals

Medical Devices

Vaccines

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

Singapore

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Pharma Wholesale and Distribution Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

AmerisourceBergen Corporation

Cardinal Health, Inc.

CuraScript, Inc.

Dakota Drug, Inc.

Fortissa

Geo-Young Co., Ltd.

Kingworld Medicines Group Limited

Mckesson Corporation

Medipal Holdings Corporation

Mutual Drug

Petrone Group

Prodigy Health LLC

Sinopharm Group Co. Ltd.

Smith Drug Co., Inc.

Walgreens Boots Alliance, Inc.

Overall world revenue for Pharma Wholesale and Distribution Market, 2024 to 2034 in terms of value the market will surpass US$800.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Pharma Wholesale and Distribution Market, 2024 to 2034 report help you?

In summary, our 300+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Pharma Wholesale and Distribution Market, 2024 to 2034 Market, with forecasts for type, distribution type, product type, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2033 for five regional and 24 key national markets - See forecasts for the Pharma Wholesale and Distribution Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Pharma Wholesale and Distribution Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Pharma Wholesale and Distribution Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Pharma Wholesale and Distribution Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Growing Global Pharmaceutical Sales
      • 3.2.1.2 Increasing Government Initiatives for Pharmaceutical Products
      • 3.2.1.3 Rising Seaborne Pharmaceutical Transportation
      • 3.2.1.4 Technological Advancements in Pharmaceutical Distribution
      • 3.2.1.5 Implementation of Track and Trace Solutions
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Stringent Regulations Imposed by Government
      • 3.2.2.2 Price Pressures Likely to Challenge Market Growth
      • 3.2.2.3 Rise in Pharmaceutical Counterfeiting
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Specializing in Niche Drugs and Therapies
      • 3.2.3.2 Embracing E-commerce and Digital Technologies
      • 3.2.3.3 Focusing on Sustainability and Ethical Sourcing
      • 3.2.3.4 Implementation of AI in Pharmaceutical Supply Chain
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Pharma Wholesale and Distribution Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 4.4 Wholesalers
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.3 Producer Wholesaler
      • 4.4.3.1 Market Size by Region, 2024-2034 (US$ Billion)
      • 4.4.3.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.4 Merchant Wholesaler
      • 4.4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
      • 4.4.4.2 Market Share by Region, 2024 & 2034 (%)
    • 4.4.5 Agents and Brokers
      • 4.4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
      • 4.4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Distributor
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
    • 4.5.3 Single Party Distributor
      • 4.5.3.1 Market Size by Region, 2024-2034 (US$ Billion)
      • 4.5.3.2 Market Share by Region, 2024 & 2034 (%)
    • 4.5.4 Multi Party Distributor
      • 4.5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
      • 4.5.4.2 Market Share by Region, 2024 & 2034 (%)

5 Pharma Wholesale and Distribution Market Analysis by Distribution Type

  • 5.1 Key Findings
  • 5.2 Distribution Type Segment: Market Attractiveness Index
  • 5.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 5.4 Ethical/Branded Pharma Products Distributors
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Generic Pharma Products Distributors
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Propaganda Cum Distribution (PCD) Franchise
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 OTC/Institutional Supply Pharma Distributors
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Pharma Wholesale and Distribution Market Analysis by Product Type

  • 6.1 Key Findings
  • 6.2 Product Type Segment: Market Attractiveness Index
  • 6.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 6.4 Branded Pharmaceuticals
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Generic Pharmaceuticals
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Over-the-counter (OTC) Pharmaceuticals
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Medical Devices
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)
  • 6.8 Vaccines
    • 6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.8.2 Market Share by Region, 2024 & 2034 (%)
  • 6.9 Others
    • 6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.9.2 Market Share by Region, 2024 & 2034 (%)

7 Pharma Wholesale and Distribution Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Pharma Wholesale and Distribution Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Pharma Wholesale and Distribution Market Attractiveness Index
  • 8.3 North America Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 8.5 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 8.6 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 8.7 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 8.8 U.S. Pharma Wholesale and Distribution Market Analysis
  • 8.9 Canada Pharma Wholesale and Distribution Market Analysis

9 Europe Pharma Wholesale and Distribution Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Pharma Wholesale and Distribution Market Attractiveness Index
  • 9.3 Europe Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 9.5 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 9.6 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 9.7 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 9.8 Germany Pharma Wholesale and Distribution Market Analysis
  • 9.9 France Pharma Wholesale and Distribution Market Analysis
  • 9.10 UK Pharma Wholesale and Distribution Market Analysis
  • 9.11 Italy Pharma Wholesale and Distribution Market Analysis
  • 9.12 Spain Pharma Wholesale and Distribution Market Analysis
  • 9.13 Russia Pharma Wholesale and Distribution Market Analysis
  • 9.14 Rest of Europe Pharma Wholesale and Distribution Market Analysis

10 Asia Pacific Pharma Wholesale and Distribution Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
  • 10.3 Asia Pacific Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 10.6 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 10.7 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 10.8 Japan Pharma Wholesale and Distribution Market Analysis
  • 10.9 China Pharma Wholesale and Distribution Market Analysis
  • 10.10 India Pharma Wholesale and Distribution Market Analysis
  • 10.11 Australia Pharma Wholesale and Distribution Market Analysis
  • 10.12 South Korea Pharma Wholesale and Distribution Market Analysis
  • 10.13 Singapore Pharma Wholesale and Distribution Market Analysis
  • 10.14 Rest of Asia Pacific Pharma Wholesale and Distribution Market Analysis

11 Latin America Pharma Wholesale and Distribution Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
  • 11.3 Latin America Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 11.5 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 11.6 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 11.7 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 11.8 Brazil Pharma Wholesale and Distribution Market Analysis
  • 11.9 Mexico Pharma Wholesale and Distribution Market Analysis
  • 11.10 Argentina Pharma Wholesale and Distribution Market Analysis
  • 11.11 Colombia Pharma Wholesale and Distribution Market Analysis
  • 11.12 Rest of Latin America Pharma Wholesale and Distribution Market Analysis

12 MEA Pharma Wholesale and Distribution Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Pharma Wholesale and Distribution Market Attractiveness Index
  • 12.3 MEA Pharma Wholesale and Distribution Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 12.4 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 12.5 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 12.6 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 12.7 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 12.8 GCC Pharma Wholesale and Distribution Market Analysis
  • 12.9 South Africa Pharma Wholesale and Distribution Market Analysis
  • 12.10 Rest of MEA Pharma Wholesale and Distribution Market Analysis

13 Company Profiles

  • 13.1 Competitive Landscape, 2022
  • 13.2 Strategic Outlook
  • 13.3 AmerisourceBergen Corporation
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2017-2022
      • 13.3.3.2 Regional Market Shares, 2022
    • 13.3.4 Service Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Cardinal Health, Inc.
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2017-2022
      • 13.4.3.2 Regional Market Shares, 2022
    • 13.4.4 Service Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 CuraScript, Inc.
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Service Benchmarking
  • 13.6 Dakota Drug, Inc.
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Service Benchmarking
  • 13.7 Fortissa
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Service Benchmarking
  • 13.8 Geo-Young Co., Ltd.
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Service Benchmarking
  • 13.9 Kingworld Medicines Group Limited
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Service Benchmarking
  • 13.10 Mckesson Corporation
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis
      • 13.10.3.1 Net Revenue, 2017-2022
      • 13.10.3.2 Regional Market Shares, 2022
    • 13.10.4 Service Benchmarking
    • 13.10.5 Strategic Outlook
  • 13.11 Medipal Holdings Corporation
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis
      • 13.11.3.1 Net Revenue, 2017-2022
    • 13.11.4 Service Benchmarking
    • 13.11.5 Strategic Outlook
  • 13.12 Mutual Drug
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Service Benchmarking
  • 13.13 Petrone Group
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Service Benchmarking
    • 13.13.4 Strategic Outlook
  • 13.14 Prodigy Health LLC
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Service Benchmarking
  • 13.15 Sinopharm Group Co. Ltd.
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Financial Analysis
      • 13.15.3.1 Net Revenue, 2017-2022
    • 13.15.4 Service Benchmarking
    • 13.15.5 Strategic Outlook
  • 13.16 Smith Drug Co., Inc.
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Service Benchmarking
  • 13.17 Walgreens Boots Alliance, Inc.
    • 13.17.1 Company Snapshot
    • 13.17.2 Company Overview
    • 13.17.3 Financial Analysis
      • 13.17.3.1 Net Revenue, 2017-2022
    • 13.17.4 Service Benchmarking
    • 13.17.5 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제